These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32747136)

  • 1. An ethical framework for the responsibilities of pharmacists when selling complementary medicines.
    Salman Popattia A; La Caze A
    Res Social Adm Pharm; 2021 May; 17(5):850-857. PubMed ID: 32747136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical responsibilities of pharmacists when selling complementary medicines: a systematic review.
    Salman Popattia A; Winch S; La Caze A
    Int J Pharm Pract; 2018 Apr; 26(2):93-103. PubMed ID: 29315916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving pharmacy practice in relation to complementary medicines: a qualitative study evaluating the acceptability and feasibility of a new ethical framework in Australia.
    Popattia AS; Hattingh L; La Caze A
    BMC Med Ethics; 2021 Jan; 22(1):3. PubMed ID: 33407396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff.
    Iyer P; McFarland R; La Caze A
    Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacists' professional practices for complementary medicines: a qualitative study in New Zealand.
    Barnes J; Butler R
    Int J Clin Pharm; 2020 Aug; 42(4):1109-1117. PubMed ID: 32686048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience.
    Ung COL; Harnett J; Hu H
    BMC Complement Altern Med; 2017 Aug; 17(1):394. PubMed ID: 28793918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advice-giving in community pharmacies in the UK.
    Tully MP; Hassell K; Noyce PR
    J Health Serv Res Policy; 1997 Jan; 2(1):38-50. PubMed ID: 10180653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a strategic model for integrating complementary medicines into professional pharmacy practice.
    Ung COL; Harnett J; Hu H
    Res Social Adm Pharm; 2018 Jul; 14(7):663-672. PubMed ID: 28784591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient experiences of over-the-counter medicine purchases in Flemish community pharmacies.
    Simoens S; Lobeau M; Verbeke K; van Aerschot A
    Pharm World Sci; 2009 Aug; 31(4):450-457. PubMed ID: 19333777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes to supervision in community pharmacy: pharmacist and pharmacy support staff views.
    Bradley F; Schafheutle EI; Willis SC; Noyce PR
    Health Soc Care Community; 2013 Nov; 21(6):644-54. PubMed ID: 23718766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting pharmacists' recommendation of complementary medicines - a qualitative pilot study of Australian pharmacists.
    Culverhouse SE; Wohlmuth H
    BMC Complement Altern Med; 2012 Oct; 12():183. PubMed ID: 23051066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review in select countries of the role of the pharmacist in consultations and sales of non-prescription medicines in community pharmacy.
    van Eikenhorst L; Salema NE; Anderson C
    Res Social Adm Pharm; 2017; 13(1):17-38. PubMed ID: 27033426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards defining and supporting pharmacists' professional role associated with traditional and complementary medicines - A systematic literature review.
    Harnett JE; Lam Ung CO
    Res Social Adm Pharm; 2023 Mar; 19(3):356-413. PubMed ID: 36404259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer-pharmacist interactions around complementary medicines: agreement between pharmacist and consumer expectations, satisfaction and pharmacist influence.
    Tran S; Calabretto JP; Sorich M
    Int J Pharm Pract; 2013 Dec; 21(6):378-85. PubMed ID: 23517229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purchasing restricted medicines in New Zealand pharmacies: results from a "mystery shopper" study.
    Norris PT
    Pharm World Sci; 2002 Aug; 24(4):149-53. PubMed ID: 12227248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.